The DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine (5-Aza-CdR) inhibits the methylase enzyme DNMT, reverses hypermethylation of the promoter region to enable reexpression of tumor-associated genes, and inhibits tumor cell growth. The gene discussed is DNMT1; the disease is neoplasm.